Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.2
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]    
Cash and cash equivalents $ 19,437 $ 31,327
Restricted cash 5,627
Accounts receivable, net 46,613 199,367
Other current assets 252,790 90,109
Inventory, net 68,421 85,243
Total current assets 392,888 406,046
Property and equipment, net 91,658 144,865
Intangible asset, net 2,536,548 2,964,979
Goodwill 3,026,036 3,026,036
Total non-current assets 5,654,242 6,135,880
Total assets 6,047,130 6,541,926
Short term bank credit 69,877 55,845
Short term loans 234,004
Trade payables 626,271 612,129
Employees and payroll accruals 1,184,185 750,872
Accrued expenses and other current liabilities 2,782,888 1,923,434
Convertible loans 1,637,577 6,567,411
Warrants presented at fair value 17,296 7,343,894
Total current liabilities 6,552,098 17,253,585
Capital note 40,000 40,000
Warrants presented at fair value 89,679 1,364,106
Israel National Authority for Technology and Innovation 381,216 755,980
Total non-current liabilities 510,895 2,160,086
Total liabilities 7,062,993 19,413,671
Ordinary shares of NIS 0.01 par value - Authorized: 1,200,000,000 as of December 31, 2021 and 2020, respectively; Issued and outstanding: 90,205,191 and 26,986,203 ordinary shares as of December 31, 2021 and 2020, respectively 270,750 73,403
Additional paid in capital 34,910,233 20,732,834
Treasury stocks (122,482) (122,482)
Accumulated deficit (36,074,364) (33,555,500)
Total shareholders’ deficit (1,015,863) (12,871,745)
Total liabilities and shareholders’ deficit $ 6,047,130 $ 6,541,926